FULGENT GENETICS, INC. Unrecognized Tax Benefits that Would Impact Effective Tax Rate
FULGENT GENETICS, INC. (FLGT) had Unrecognized Tax Benefits that Would Impact Effective Tax Rate of $2.50 million as of 2024-12-31, per its 10-K filed 2025-02-28.
Financial Statements › Notes › Income Taxes › Income Tax Uncertainties
us-gaap:UnrecognizedTaxBenefitsThatWouldImpactEffectiveTaxRate · last filed 2025-02-28
- 2024-12-31: Unrecognized Tax Benefits that Would Impact Effective Tax Rate $2.50M.
- 2023-12-31: Unrecognized Tax Benefits that Would Impact Effective Tax Rate $2.30M.
- 2022-12-31: Unrecognized Tax Benefits that Would Impact Effective Tax Rate $2.30M.
- 2021-12-31: Unrecognized Tax Benefits that Would Impact Effective Tax Rate $710.00K.
| Period end | Unrecognized Tax Benefits that Would Impact Effective Tax Rate |
|---|---|
| 2024-12-31 | $2.50M 10-K · filed 2025-02-28 |
| 2023-12-31 | $2.30M 10-K · filed 2024-02-28 |
| 2022-12-31 | $2.30M 10-K · filed 2023-02-28 |
| 2021-12-31 | $710.00K 10-K · filed 2022-02-28 |
| 2020-12-31 | $377.00K 10-K · filed 2021-03-08 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| BIODESIX INC (BDSX) | United States | $0.312B | |
| Lumexa Imaging Holdings, Inc. (LMRI) | United States | $0.951B | |
| EXAGEN INC. (XGN) | United States | $0.212B | -5.95 |
| Freenome, Inc. (FRNM) | United States | $0.143B | |
| CASTLE BIOSCIENCES INC (CSTL) | United States | $1.074B | -37.45 |
| SERA PROGNOSTICS, INC. (SERA) | United States | $0.062B | -5.75 |
| AMERICAN SHARED HOSPITAL SERVICES (AMS) | United States | $0.010B | -5.64 |
| Advanced Biomed Inc. (ADVB) | $0.009B | ||
| Aclarion, Inc. (ACON) | United States | $0.008B | |
| BioNexus Gene Lab Corp (BGLC) | $0.004B |